Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3091263 Target Snapshot

GMP-stimulated 3',5'-cyclic nucleotide phosphodiesterase · SINGLE PROTEIN · Macaca mulatta

755Compounds
9Assays
0Approved Drugs
913.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt B3VTJ2. Use UniProt B3VTJ2 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt B3VTJ2 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats GMP-stimulated 3',5'-cyclic nucleotide phosphodiesterase as ChEMBL target CHEMBL3091263, mapped to UniProt B3VTJ2. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
GMP-stimulated 3',5'-cyclic nucleotide phosphodiesterase
SINGLE PROTEIN · Macaca mulatta
As of 2026-09-14
ChEMBL target ID
CHEMBL3091263
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
B3VTJ2
Phosphodiesterase
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether GMP-stimulated 3',5'-cyclic nucleotide phosphodiesterase is the right protein anchor across sources, using UniProt B3VTJ2 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelPhosphodiesterase
UniProt AccessionB3VTJ2
Component TypeProtein
Sequence Length941 aa

Phosphodiesterase

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as GMP-stimulated 3',5'-cyclic nucleotide phosphodiesterase, mapped to UniProt B3VTJ2. ChEMBL maps the protein component as Phosphodiesterase. Sequence length is 941 aa.

Mapped IDB3VTJ2
Review nameGMP-stimulated 3',5'-cyclic nucleotide phosphodiesterase
OrganismMacaca mulatta
Assay Mix

Activity Type Distribution

IC501.0
KI912.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3092564 10.0 IC50 0.1 Preclinical
CHEMBL5847109 10.0 Ki 0.1 Preclinical
CHEMBL5830637 9.96 Ki 0.11 Preclinical
CHEMBL5847051 9.96 Ki 0.11 Preclinical
CHEMBL5922620 9.96 Ki 0.11 Preclinical
CHEMBL6029690 9.96 Ki 0.11 Preclinical
CHEMBL5744255 9.92 Ki 0.12 Preclinical
CHEMBL5915385 9.92 Ki 0.12 Preclinical
CHEMBL5876913 9.85 Ki 0.14 Preclinical
CHEMBL5940967 9.85 Ki 0.14 Preclinical
Distribution

pChEMBL Value Distribution

21
5.0
64
5.5
78
6.0
75
6.5
131
7.0
138
7.5
151
8.0
115
8.5
79
9.0
26
9.5
pChEMBL
Assay Landscape

Assay Landscape

9
Total Assays
750
Tested Compounds
1
Assay Types
Binding — 9 assays, 750 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 6 722 7.6
single protein format 2 23 6.7
cell-based format 1 5 9.3

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine